Structure-based specificity mapping of secreted aspartic proteases of Candida parapsilosis, Candida albicans, and Candida tropicalis using peptidomimetic inhibitors and homology modeling
暂无分享,去创建一个
Pavel Majer | Filip Majer | I. Pichová | P. Majer | F. Majer | Martin Hradilek | Libuše Pavlíčková | Elena Dolejší | Olga Hrušková-Heidingsfeldová | Iva Pichová | L. Pavlíčková | M. Hradílek | E. Dolejsí | O. Hrušková-Heidingsfeldová
[1] A. Edison,et al. Comparison of the extracellular proteinase activity produced by a low-virulence mutant of Candida albicans and its wild-type parent , 1988, Infection and immunity.
[2] R. Johnson. Renin inhibitors. Substitution of the leucyl residues of Leu-Leu-Val-Phe-OCH3 with 3-amino-2-hydroxy-5-methylhexanoic acid. , 1982, Journal of medicinal chemistry.
[3] F. Salituro,et al. Inhibition of aspartic proteases by pepstatin and 3-methylstatine derivatives of pepstatin. Evidence for collected-substrate enzyme inhibition. , 1985, Biochemistry.
[4] T. L. Blundell,et al. High resolution X-ray analyses of renin inhibitor-aspartic proteinase complexes , 1987, Nature.
[5] D. Nisato,et al. Stereospecific synthesis of N-protected statine and its analogues via chiral tetramic acid , 1987 .
[6] I. Pichová,et al. Enzymological Characterization of Secreted Proteinases from Candida parapsilosis and Candida lusitaniae , 2001 .
[7] J. Collins,et al. Structure‐based subsite specificity mapping of human cathepsin D using statine‐based inhibitors , 1997, Protein science : a publication of the Protein Society.
[8] K. Haynes. Virulence in Candida species. , 2001, Trends in microbiology.
[9] P. Tamburini,et al. Role of aspartic proteases in disseminated Candida albicans infection in mice , 1997, Infection and immunity.
[10] T. Bertsch,et al. Germ Tubes and Proteinase Activity Contribute to Virulence of Candida albicans in Murine Peritonitis , 1999, Infection and Immunity.
[11] D. Coy,et al. Solid phase synthesis of peptides containing the CH2NH peptide bond isostere , 1987, Peptides.
[12] D. Rich,et al. Inhibition of cathepsin D by substrate analogues containing statine and by analogues of pepstatin. , 1986, Journal of medicinal chemistry.
[13] T L Blundell,et al. X-ray studies of aspartic proteinase-statine inhibitor complexes. , 1991, Biochemistry.
[14] S. C. Smith,et al. Synthesis of all the stereoisomers of statine (4-amino-3-hydroxy-6-methylheptanoic acid). Inhibition of pepsin activity by N-carbobenzoxy-L-valyl-L-valyl-statine derived from the four stereoisomers. , 1979, Journal of medicinal chemistry.
[15] B. Dunn,et al. Extracellular aspartic proteinases from Candida albicans, Candida tropicalis, and Candida parapsilosis yeasts differ substantially in their specificities. , 1994, Biochemistry.
[16] I. Pichová,et al. Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitors. , 2001, European journal of biochemistry.
[17] J. Symerský,et al. High-resolution structure of the extracellular aspartic proteinase from Candida tropicalis yeast. , 1997, Biochemistry.
[18] A. Cassone,et al. Biotyping and Virulence Properties of Skin Isolates ofCandida parapsilosis , 1999, Journal of Clinical Microbiology.
[19] I. Pichová,et al. Simple Method for Screening Candida Species Isolates for the Presence of Secreted Proteinases: a Tool for the Prediction of Successful Inhibitory Treatment , 2003, Journal of Clinical Microbiology.
[20] B. Hube,et al. Candida albicans proteinases: resolving the mystery of a gene family. , 2001, Microbiology.
[21] B. Dunn. Structure and mechanism of the pepsin-like family of aspartic peptidases. , 2002, Chemical reviews.
[22] S. Foundling,et al. Enzymic characteristics of secreted aspartic proteases of Candida albicans. , 2000, Biochimica et biophysica acta.
[23] Professor Dr. Miklos Bodanszky,et al. The Practice of Peptide Synthesis , 1994, Springer Lab Manual.
[24] C. Abad-Zapatero,et al. Candida proteases and their inhibition: prospects for antifungal therapy. , 2001, Current medicinal chemistry.
[25] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[26] J. Navaza,et al. Structure of a secreted aspartic protease from C. albicans complexed with a potent inhibitor: Implications for the design of antifungal agents , 1996, Protein science : a publication of the Protein Society.
[27] J. F. Höfling,et al. Candida albicans proteinases , 2006 .
[28] R. Falchetto,et al. Cloning and sequencing of two Candida parapsilosis genes encoding acid proteases. , 1993, Journal of general microbiology.
[29] C. Abad-Zapatero,et al. Antifungal drug targets: Candida secreted aspartyl protease and fungal wall beta-glucan synthesis. , 1995, Infectious agents and disease.
[30] G. Gilfillan,et al. Candida dubliniensis: phylogeny and putative virulence factors. , 1998, Microbiology.
[31] Dan Backman,et al. Kinetic and mechanistic analysis of the association and dissociation of inhibitors interacting with secreted aspartic acid proteases 1 and 2 from Candida albicans. , 2003, Biochimica et biophysica acta.
[32] G. Santoni,et al. De Bernardis, F. et al. Protective role of anti-mannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect. Immun. 65, 3399-3405 , 1997 .
[33] T. Aoyagi,et al. Pepstatin, a new pepsin inhibitor produced by Actinomycetes. , 1970, The Journal of antibiotics.
[34] B. Anderson,et al. The crystal structure of a major secreted aspartic proteinase from Candida albicans in complexes with two inhibitors. , 1995, Structure.
[35] S. Challacombe,et al. Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis , 2003, Microbiology and Molecular Biology Reviews.
[36] B. Hube,et al. Multiplicity of genes encoding secreted aspartic proteinases in Candida species , 1994, Molecular microbiology.
[37] U. Reichard,et al. Secreted Aspartic Proteinase Family ofCandida tropicalis , 2001, Infection and Immunity.
[38] J. Bobbitt,et al. Organic oxoammonium salts. 3. A new convenient method for the oxidation of alcohols to aldehydes and ketones , 1991 .
[39] P. Štrop,et al. Cloning, Bacterial Expression, and Characterization of the Mason-Pfizer Monkey Virus Proteinase (*) , 1995, The Journal of Biological Chemistry.